These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9284765)

  • 1. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells.
    Bamberger AM; Schulte HM; Thuneke I; Erdmann I; Bamberger CM; ASA SL
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3173-5. PubMed ID: 9284765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of functional Fas ligand in choriocarcinoma.
    Hammer A; Hartmann M; Sedlmayr P; Walcher W; Kohnen G; Dohr G
    Am J Reprod Immunol; 2002 Oct; 48(4):226-34. PubMed ID: 12516633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placental Fas ligand expression is a mechanism for maternal immune tolerance to the fetus.
    Kauma SW; Huff TF; Hayes N; Nilkaeo A
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2188-94. PubMed ID: 10372730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas and Fas-ligand are expressed in the uteroplacental unit of first-trimester pregnancy.
    Hammer A; Blaschitz A; Daxböck C; Walcher W; Dohr G
    Am J Reprod Immunol; 1999 Jan; 41(1):41-51. PubMed ID: 10097786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease.
    Mor G; Gutierrez LS; Eliza M; Kahyaoglu F; Arici A
    Am J Reprod Immunol; 1998 Aug; 40(2):89-94. PubMed ID: 9764350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines.
    Rajashekhar G; Loganath A; Roy AC; Mongelli JM
    Gynecol Oncol; 2003 Oct; 91(1):101-11. PubMed ID: 14529668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First trimester trophoblast cells secrete Fas ligand which induces immune cell apoptosis.
    Abrahams VM; Straszewski-Chavez SL; Guller S; Mor G
    Mol Hum Reprod; 2004 Jan; 10(1):55-63. PubMed ID: 14665707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Labor-associated changes in Fas ligand expression and function in human placenta.
    Balkundi DR; Hanna N; Hileb M; Dougherty J; Sharma S
    Pediatr Res; 2000 Mar; 47(3):301-8. PubMed ID: 10709727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion.
    Uckan D; Steele A; Cherry ; Wang BY; Chamizo W; Koutsonikolis A; Gilbert-Barness E; Good RA
    Mol Hum Reprod; 1997 Aug; 3(8):655-62. PubMed ID: 9294848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching the tissue immune privilege hypothesis from cellular to vesicular level.
    Frängsmyr L; Baranov V; Nagaeva O; Stendahl U; Kjellberg L; Mincheva-Nilsson L
    Mol Hum Reprod; 2005 Jan; 11(1):35-41. PubMed ID: 15579659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines.
    Phillips TA; Ni J; Hunt JS
    Placenta; 2001; 22(8-9):663-72. PubMed ID: 11597186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to Fas-mediated cell death in BeWo and NJG choriocarcinoma cell lines: implications in immune privilege.
    Rajashekhar G; Loganath A; Roy AC; Mongelli JM
    Gynecol Oncol; 2003 Oct; 91(1):89-100. PubMed ID: 14529667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The tumor suppressor gastrokine-1 is expressed in placenta and contributes to the regulation of trophoblast migration.
    Fahlbusch FB; Ruebner M; Huebner H; Volkert G; Zuern C; Thiel F; Koch M; Menendez-Castro C; Wachter DL; Hartner A; Rascher W
    Placenta; 2013 Nov; 34(11):1027-35. PubMed ID: 23993393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces.
    Guller S; LaChapelle L
    Semin Reprod Endocrinol; 1999; 17(1):39-44. PubMed ID: 10406074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coelomic cells show apoptosis via Fas/FasL system: a comparative study between healthy human pregnancies and missed miscarriages.
    Kaponis A; Skyrlas A; Zagorianakou N; Georgiou I; Passa V; Paraskevaidis E; Makrydimas G
    Hum Reprod; 2008 May; 23(5):1159-69. PubMed ID: 18316328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the colony stimulating factor-1 receptor (c-fms product) by cells at the human uteroplacental interface.
    Jokhi PP; Chumbley G; King A; Gardner L; Loke YW
    Lab Invest; 1993 Mar; 68(3):308-20. PubMed ID: 8450649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy.
    Pongcharoen S; Searle RF; Bulmer JN
    Placenta; 2004 Apr; 25(4):321-30. PubMed ID: 15028424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of FasL/Fas in human trophoblasts: possible implications for chorioamnionitis.
    Balkundi DR; Ziegler JA; Watchko JF; Craven C; Trucco M
    Biol Reprod; 2003 Aug; 69(2):718-24. PubMed ID: 12700199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of Fas/FasL and apoptosis in yak placentomes.
    JiangFeng F; Jiu YS; Wen ZZ; Ben L
    Anim Reprod Sci; 2011 Oct; 128(1-4):107-16. PubMed ID: 22014664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the expression of Fas ligand on the surfaces of human cytotrophoblasts in normal pregnancy].
    Qiu H; Sun Y
    Zhonghua Fu Chan Ke Za Zhi; 2001 Jul; 36(7):402-4. PubMed ID: 11718024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.